ArticleMolecular and clinical oncology2021

HER2-amplified metastatic lung adenocarcinoma responds to fourth-line pyrotinib therapy: A case report.

Kan Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.